Arkansas Diabetes and Endocrinology Center

Today is a day that we never wanted to experience. Today we brought our Paramedic Mark Gibson home. We want to thank everyone for the outpouring of love and support.

Launch Your Healthcare Career: Entry-Level Medical Assistant (No Nights/Weekends!)

Do you have a passion for helping others and a desire to join a fast-paced medical setting?

We're seeking a motivated and organized individual to join our team as an Entry-Level Medical Assistant! In this role, you'll play a vital role in supporting our healthcare professionals and ensuring a positive patient experience.

What you'll do:

Assist healthcare providers with clinical tasks
Manage patient flow
Update and maintain medical records
Perform administrative duties

A friendly and compassionate demeanor
Excellent communication and interpersonal skills
Strong organizational skills and a knack for multitasking
A willingness to learn and grow in the medical field
What we offer:

Benefits package, including medical, dental, and vision insurance
Personal time off (PTO) accrual
Major holidays off
Best Part: No nights, weekends, and you get out early on Fridays!
Ready to take the first step in your healthcare career?

If interested send cover letter including contact information and resume to [email protected]

Dr. Thrasher on an Expert Panel after discussing our research and clinical experience during an Education Program on Advancing Automation with the MiniMed ™ 780G System. Two groups of healthcare professionals attended the 2 day program looking to achieve optimal outcomes with this system.

The ADEC clinicians stay up to date by attending annual educational and research conferences. The latest thyroid technology and interventions (ultrasound artificial intelligence, fine needle aspiration and radiofrequency ablation), PCOS, adrenal and pituitary disorders, nutritional, diabetes therapies and technology and general endocrinology. AACE 2024 New Orleans, LA

Did you hear Dr. James Thrasher share the early MiniMed™ 780G system real-world data from the U.S. at ? See link below for more details.

www.linkedin.com

Press release from Dr Thrasher’s presentation this morning at the 17th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD)

MiniMed™ 780G System Early Success in the U.S.
In an oral presentation, Dr. James Thrasher, MD, Founder, Arkansas Diabetes and Endocrinology Center, shared data on early real-world users with type 1 diabetes of the MiniMed™ 780G system in the U.S. (n=7,499). Results showed users achieved over 80% TIR when employing the recommended optimal settings, exceeding international glycemic targets (ADA guidelines recommend 70% time in range between 70-180 mg/dL), with closed loop exits occurring less than once per week on average. The enhancements introduced in this latest system have resulted in high satisfaction and improved quality of life benefits.15,16 Indeed, the latest dQ&A U.S. Pump Patient Survey (n=1,997), found that among pump users, the MiniMed™ 780G system scored first in overall pump satisfaction.*,17 The survey also showed that among people with type 1 diabetes using CGM, the Guardian™ 4 sensor mirrored competitor sensors in overall satisfaction.*,18

"The results demonstrate that when the MiniMed™ 780G system is optimized with recommended optimal settings, it helps people with diabetes far exceed the ADA recommended goal of 70% Time in Range,*" said Dr. Thrasher. "The advent of AID systems has been nothing short of transformative in the practice of endocrinology and is really pushing all of us to introduce its protective benefits on overall health as early and often as possible. This data reinforces that the determinant of choice for AID systems should be first and foremost the power of the algorithm."

New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management Medtronic plc. (NYSE: MDT), a global leader in healthcare technology, today shared a robust set of new clinical and real-world evidence on the MiniMed™ 780G system from around the world including the largest set of data from early users in the United States. The data was presented at the 17th Inte...

American Journal Medicine on Heart Failure by Rhonda Moore & Dr. Thrasher. He writes plain language overview of HF suitable for non-medical professionals See link

www.amjmed.com

You can now get a Dexcom CGM Over-the-Counter! Hopefully CGM will make glucose meters a thing of the past. This is a great start!

FDA Clears First Over-the-Counter Continuous Glucose Monitor Today, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter continuous glucose monitor.

https://www.usms.org/fitness-and-training/articles-and-videos/articles/how-swimming-might-improve-pain-tolerance

How Swimming Might Improve Pain Tolerance If you sometimes wonder why you put yourself through the pain of tough workout after tough workout, you’re not alone. But in what may seem like a paradoxical relationship, fighting through the pain of a challenging swim could be a smart, drug-free way to reduce or manage other kinds of pain. That....

https://i.snoball.it/p/FiOa/i/5
Video soundbite of Dr. James Thrasher's oral presentation at the 17th International Conference on Advanced Technologies and Treatments for Diabetes, in Florence, Italy.

The Future is at ATTD Our community strives to discuss, exchange and discover the latest novelties and advancements.

New article published by Dr. James Thrasher and Kate Cameron, two of our providers and researchers at ADEC on “Early Real-World Performance of the MiniMed 780GAdvanced Hybrid Closed-Loop System and RecommendedSettings Use in the United States.” CLICK LINK BELOW

https://www.liebertpub.com/doi/epdf/10.1089/dia.2023.0453

We are excited to highlight Kate Cameron who will be a speaker on PCOS at the ARAPA 2024 conference! Sharing her endocrine expertise to educate others. Arkansas Academy of PAs

Sign up now for the 2024 ARAPA CME Conference!

https://arapa.mypanetwork.com/physician-assistant-events/945-cme-conference-2024 #!registration

It was great speaking for Medtronic Diabetes sharing our research and clinical experience with Medtronic 780G Artificial Pancreas System. Having our newest PA Sara Pinkerton and our Medtronic Trainer Ashley Sutherland Steele.

This is the Disposable Sensor that we researched in our center. It has gained approval in Europe and hopefully we will see FDA approval in the US soon. It will be called Simplera Sync in Europe. We are leading the way in bringing simplicity for diabetes treatment in Arkansas

Medtronic wins CE mark for MiniMed 780G with Simplera Sync Medtronic (NYSE:MDT) announced today that it received CE mark approval for its MiniMed 780G system with Simplera Sync.

The clinic staff and Dr. Thrasher brings on a big to support in the

Merry Christmas to all!

It’s already been five years and now we see CGMs commonly used. Technology is helping diabetes become less burdensome, When combined with an AID insilin pump the basal and correction bolus insulin can be automatically delivered. Giving people with diabetes more of their life back.We are only 1 of 2 centers that can insert this system in Arkansas.

Congratulations to Dr. James Thrasher for 3 successful implants of Eversense 90 day Continuous Glucose Monitors today! Now we have 6 patients on this technology in Arkansas, ALL done at ADEC! Leader in diabetes technology, research and medicine. Thanks to the Senseonics staff for flying in to assist us.

Our Annual ADEC Christmas Party. We came together, research and clinic, breaking bread together, exchanging gifts , and having a wonderful time together before closing down the Christmas Holiday. Merry Christmas to all that trust your healthcare with us at ADEC. God bless!

100 years ago, Sir Frederick Grant Banting and Professor John James Rickard Macleod were awarded the prestigious for their groundbreaking discovery of , which they patented for just $1.

Just like Banting and Macleod, the American Diabetes Association® is dedicated to ensuring access to insulin for all. 💙🔬Learn more at bit.ly/46xaSdT.

An abstract that Kate Cameron, PA-C,RD and Dr. James Thrasher authored was selected as an oral presentation in Florence, Italy. Quite an honor to get to present at a global conference.

Dear Dr. James Thrasher,
Congratulations once again on your abstract being awarded an oral presentation by the ATTD 2024 Scientific committee. Oral presentations will be given in person at the 17th International Conference on Advanced Technologies & Treatments for Diabetes in Florence, Italy, 6-9 March 2024.

Abstract title: EARLY REAL-WORLD PERFORMANCE OF THE MINIMED™ 780G ADVANCED HYBRID CLOSED-LOOP (AHCL) SYSTEM AND RECOMMENDED SETTINGS USE IN THE UNITED STATES

When the staff supports Dr. Thrasher’s Michigan football team. Go Blue!

We are thankful for the PA’s, MA’s, medical receptionists, clinical research coordinators, research pump trainers, medical billing and coding, referral coordinators, the directors and management that keeps our clinic and research center flowing efficiently for all our patients and research subjects.
Dr. James and Lesa Thrasher

I you received a letter from United Healthcare that states we are no longer in network this is not correct. We are and still will be in network with UHC. If you still have a question you can call the number listed to verify that we are in network. We are trying to reach out to everyone who may have received this incorrect notice. You do not have to change providers or change your policy to continue to your care at our clinic.

Two of our providers, James Thrasher, MD, and Kate Cameron, PA-C, RD have authored, along with others, an abstract submitted to the ATTD 2024 Diabetes Congress. This has been accepted as an Oral Presentation at the Conference in Florence, Italy, on 6-9 March 2024. Titled "Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop (AHCL) System and Recommended Settings Use in the United States," this abstract will be published in the peer-reviewed journal 𝐷𝑖𝑎𝑏𝑒𝑡𝑒𝑠 𝑇𝑒𝑐ℎ𝑛𝑜𝑙𝑜𝑔𝑦 & 𝑇ℎ𝑒𝑟𝑎𝑝𝑒𝑢𝑡𝑖𝑐𝑠, published by Mary Ann Liebert, Inc.
Our Center is leading the way in Arkansas, conducting globally recognized diabetes technology research.

ATTD 2024: Diabetes Congress, 6-9 March Join us for ATTD 2024, the 17th International Conference on Advanced Technologies & Treatments for Diabetes. See you in Florence, 6-9 March.

As the diabetes world works toward a cure, we have made incredible breakthroughs in managing type 1 diabetes and bringing remission of type 2 diabetes. Due to the prevalence of diabetes and its affect on the lives of so many, the world strives to be more educated about the different types of diabetes and support those that struggle with diabetes or care for someone with diabetes.

We are grateful to every Veteran who served our country 🇺🇸

We are so proud of this girl. She is our Champion!

Blue might usually be the color for , but Raylee is rocking this all-pink look AND her ! 💗

The system is for type 1 ages 7 and over. Prescription required. WARNING: Do not use SmartGuard™ feature for people who require less than 8 units or more than 250 units of insulin/day. See bit.ly/780gRisks.

Celebrate Respiratory Care Week. We are so blessed to have Lesa Thrasher,RRT,CCRP who worked as Respiratory Therapist at UAMS before going into research. She is the Director of Clinical Research at our center.